Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples